Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor.
Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor.
JAMA Surg. 2019 Jul 1;154(7):637-646. doi: 10.1001/jamasurg.2019.0418.
Optimal treatment for traumatic digit amputation is unknown.
To compare long-term patient-reported and functional outcomes between patients treated with revision amputation or replantation for digit amputations.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at 19 centers in the United States and Asia. Participants were 338 individuals 18 years or older with traumatic digit amputations with at least 1 year of follow-up after treatment. Participants were enrolled from August 1, 2016, to April 12, 2018.
Revision amputation or replantation of traumatic digit amputations.
The primary outcome was the Michigan Hand Outcomes Questionnaire (MHQ) score. Secondary outcomes were the 36-Item Short Form Health Survey (SF-36), Disabilities of the Arm, Shoulder, and Hand (DASH), and Patient-Reported Outcomes Measurement Information System (PROMIS) upper-extremity module scores and functional outcomes.
Among 338 patients who met all inclusion criteria, the mean (SD) age was 48.3 (16.4) years, and 85.0% were male. Adjusted aggregate comparison of patient-reported outcomes (PROs) between patients with revision amputation and replantation revealed significantly better outcomes in the replantation cohort measured by the MHQ (5.93; 95% CI, 1.03-10.82; P = .02), DASH (-4.29; 95% CI, -8.45 to -0.12; P = .04), and PROMIS (3.44; 95% CI, 0.60 to 6.28; P = .02) scores. In subgroup analyses, DASH scores were significantly lower (6 vs 9, P = .05), indicating less disability and pain, and PROMIS scores higher (78 vs 75, P = .04) after replantation. Patients with 3 or more digits amputated (including thumb) had significantly better PROs after replantation than those managed with revision amputation (22 vs 42, P = .03 for DASH and 61 vs 36, P = .01 for PROMIS). Patients who underwent replantation after 3 or more digits amputated (excluding thumb) had higher MHQ scores, which did not reach statistical significance (69 vs 65, P = .06). Revision amputation in the subgroup with single-finger amputation distal to the proximal interphalangeal joint resulted in better 2-point discrimination (6 vs 8 mm, P = .05). Compared with revision amputation, replantation resulted in better 9-hole peg test times in the subgroup with 3 or more digits amputated (including thumb) (46 vs 81 seconds, P = .001), better Semmes-Weinstein monofilament test in the subgroup with 3 or more digits amputated (excluding thumb) (3 vs 21 g, P = .008), and better 3-point pinch test in the subgroup with 2 digits amputated (excluding thumb) (6.7 vs 5.6 kg, P = .03).
When technically feasible, replantation is recommended in 3 or more digits amputated and in single-finger amputation (excluding thumb) distal to the proximal interphalangeal joint because it achieved better PROs, with long-term functional benefit. Thumb replantation is still recommended for its integral role in opposition.
创伤性断指的最佳治疗方法尚不清楚。
比较对断指患者进行 Revision 截肢术或再植术治疗的长期患者报告和功能结果。
设计、地点和参与者:在美国和亚洲的 19 个中心进行的回顾性队列研究。参与者为 338 名年龄在 18 岁或以上的创伤性断指患者,在接受治疗后至少有 1 年的随访。参与者于 2016 年 8 月 1 日至 2018 年 4 月 12 日入组。
创伤性断指的 Revision 截肢术或再植术。
主要结局是密歇根手部结果问卷(MHQ)评分。次要结局是 36 项简短健康调查(SF-36)、上肢肩臂手残疾量表(DASH)、患者报告结局测量信息系统(PROMIS)上肢模块评分和功能结局。
在符合所有纳入标准的 338 名患者中,平均(SD)年龄为 48.3(16.4)岁,85.0%为男性。对 Revision 截肢术和再植术患者的患者报告结局(PROs)进行的调整后综合比较显示,再植术组的 MHQ(5.93;95%CI,1.03-10.82;P=0.02)、DASH(-4.29;95%CI,-8.45 至-0.12;P=0.04)和 PROMIS(3.44;95%CI,0.60 至 6.28;P=0.02)评分明显更好。在亚组分析中,DASH 评分显著更低(6 分比 9 分,P=0.05),表明疼痛和残疾程度更低,PROMIS 评分更高(78 分比 75 分,P=0.04)。3 个或更多手指(包括拇指)截肢的患者再植后 PROs 明显更好,而 Revision 截肢术患者则较差(DASH 22 分比 42 分,P=0.03;PROMIS 61 分比 36 分,P=0.01)。3 个或更多手指(不包括拇指)截肢后再植的患者 MHQ 评分更高,但未达到统计学意义(69 分比 65 分,P=0.06)。在单一手指(近节指间关节远端)截肢的亚组中,Revision 截肢术导致更好的 2 点辨别觉(6 毫米比 8 毫米,P=0.05)。与 Revision 截肢术相比,再植术在 3 个或更多手指(包括拇指)截肢的亚组中可获得更好的 9 孔钉测试时间(46 秒比 81 秒,P=0.001)、在 3 个或更多手指(不包括拇指)截肢的亚组中更好的 Semmes-Weinstein 单丝试验(3 克比 21 克,P=0.008)和在 2 个手指(不包括拇指)截肢的亚组中更好的 3 点捏测试(6.7 千克比 5.6 千克,P=0.03)。
在技术可行的情况下,推荐对 3 个或更多手指截肢和近节指间关节远端的单一手指(不包括拇指)截肢进行再植术,因为其可获得更好的 PROs,具有长期功能益处。拇指再植术仍被推荐用于其在对掌中的重要作用。